Clarivate PLC：有机增长回归确认投机吸引力（NYSE:CLVT）
· seekingalpha.com
Clarivate PLC股价在发布稳健的Q3业绩及6亿美元生命科学业务剥离后飙升40%，降低了杠杆并强化了业务聚焦。请在此处了解更多关于CLVT的信息。
If you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major e...